These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7429746)

  • 1. Differentiation of chronic schizophrenics with and without ventricular enlargement by the Luria-Nebraska Neuropsychological Battery.
    Golden CJ; Graber B; Moses JA; Zatz LM
    Int J Neurosci; 1980; 11(2):131-8. PubMed ID: 7429746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral ventricular size and neuropsychological impairment in young chronic schizophrenics. Measurement by the standardized Luria-Nebraska Neuropsychological Battery.
    Golden CJ; Moses JA; Zelazowski R; Graber B; Zatz LM; Horvath TB; Berger PA
    Arch Gen Psychiatry; 1980 Jun; 37(6):619-23. PubMed ID: 6966917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-validation of the ability of the Luria-Nebraska Neuropsychological Battery to differentiate chronic schizophrenics with and without ventricular enlargement.
    Golden CJ; MacInnes WD; Ariel RN; Ruedrich SL; Chu CC; Coffman JA; Graber B; Bloch S
    J Consult Clin Psychol; 1982 Feb; 50(1):87-95. PubMed ID: 7056923
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of brain-damage in schizophrenics as measured by the Whitaker Index of Schizophrenic Thinking and the Luria-Nebraska Neuropsychological Battery.
    Puente AE; Heidelberg-Sanders C; Lund N
    Percept Mot Skills; 1982 Apr; 54(2):495-9. PubMed ID: 7079075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination between schizophrenic and brain-damaged patients with the Luria Nebraska Neuropsychological Test Battery.
    Moses JA; Golden CJ
    Int J Neurosci; 1980; 10(2-3):121-8. PubMed ID: 7364541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of schizophrenics with and without nervous system damage using the Luria-Nebraska Neuropsychological Battery.
    Puente AE; Heidelberg-Sanders C; Lund NL
    Int J Neurosci; 1982 Feb; 16(1):59-62. PubMed ID: 7169277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia.
    Pfefferbaum A; Zipursky RB; Lim KO; Zatz LM; Stahl SM; Jernigan TL
    Arch Gen Psychiatry; 1988 Jul; 45(7):633-40. PubMed ID: 3382323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does depression in patients with known or suspected cerebral disease contribute to impairment on the Luria-Nebraska Neuropsychological Battery?
    Heinrichs RW
    Int J Neurosci; 1987 Feb; 32(3-4):895-9. PubMed ID: 3596933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenic subgroups with normal and abnormal cognitive functioning on the Luria-Nebraska Neuropsychological Battery.
    Moses JA
    Int J Neurosci; 1983 Oct; 21(1-2):129-35. PubMed ID: 6671868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological differentiation of chronic schizophrenia.
    Puente AE; Rodenbough J; Orrell TD
    Int J Neurosci; 1993 Oct; 72(3-4):193-200. PubMed ID: 7908012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical evaluation of diagnostic rules for evaluation of Luria-Nebraska Neuropsychological Battery profiles of chronic schizophrenic, schizoaffective, and brain-damaged patients.
    Moses JA; Thompson LL; Cardellino JP; Johnson GL
    Int J Neurosci; 1983 Oct; 21(1-2):119-27. PubMed ID: 6671867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor analysis of the Luria-Nebraska Neuropsychological Battery. I. Motor, rhythm, and tactile scales.
    Golden CJ; Sweet J; Hammeke T; Purisch A; Graber B; Osmon D
    Int J Neurosci; 1980; 11(2):91-9. PubMed ID: 7429748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of relationship of neuroleptic dose and blood serum levels to neuropsychological performance on the LNNB in chronic schizophrenia.
    Puente AE; Tune L
    Int J Neurosci; 1996 Oct; 87(1-2):107-10. PubMed ID: 8913825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological deficits in chronic schizophrenics. Relationship with symptoms and behavior.
    Dickerson FB; Ringel NB; Boronow JJ
    J Nerv Ment Dis; 1991 Dec; 179(12):744-9. PubMed ID: 1744633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomographic brain studies and treatment response in schizophrenia.
    Bird JM
    Can J Psychiatry; 1985 Jun; 30(4):251-4. PubMed ID: 3874681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological impairment with schizophrenia vs. acute and chronic cerebral lesions.
    Heaton RK; Vogt AT; Hoehn MM; Lewis JA; Crowley TJ; Stallings MA
    J Clin Psychol; 1979 Jan; 35(1):46-53. PubMed ID: 422730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular enlargement and neuropsychological testing in schizophrenia.
    Obiols JE; Marcos T; Salamero M
    Acta Psychiatr Scand; 1987 Aug; 76(2):199-202. PubMed ID: 3673643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological dysfunction in schizophrenia. Relation to associative thought disorder.
    Silverstein ML; Arzt AT
    J Nerv Ment Dis; 1985 Jun; 173(6):341-6. PubMed ID: 3998719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia in schizophrenia. Magnetic resonance and clinical correlates.
    Rossi A; Galderisi S; Di Michele V; Stratta P; Ceccoli S; Maj M; Casacchia M
    J Nerv Ment Dis; 1990 Aug; 178(8):521-4. PubMed ID: 2380699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luria-Nebraska performance and symptomatology in unmedicated schizophrenic patients.
    Faustman WO; Moses JA; Csernansky JG
    Psychiatry Res; 1988 Oct; 26(1):29-34. PubMed ID: 3237904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.